Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review
| Primer Autor |
Sandoval, Cristian
|
| Co-autores |
Guerrero, Daniela
Munoz, Joham
Godoy, Karina
Souza-Mello, Vanessa
Farias, Jorge
|
| Título |
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review
|
| Editorial |
TAYLOR & FRANCIS LTD
|
| Revista |
EXPERT REVIEW OF VACCINES
|
| Lenguaje |
en
|
| Resumen |
Introduction: Vaccines prevent disease and disability, save lives and represent a good assessment of health interventions. Several systematic reviews on the efficacy and effectiveness of COVID-19 vaccines have been published, but the immunogenicity and safety of these vaccines should also be addressed. Areas covered: This systemic investigation sought to explain the efficacy, immunogenicity, and safety of new vaccination technologies against SARS-CoV-2 in people over 18 years old. Original research studying the effectiveness on mRNA, protein subunit vaccines, and viral vector vaccines against SARS-CoV-2 in people over 18 years old was analyzed. Several databases (Web of Science, Scopus, MEDLINE and EMBASE) were searched between 2012 and November 2022 for English-language papers using text and MeSH terms related to SARS-CoV-2, mechanism, protein subunit vaccine, viral vector, and mRNA. The protocol was registered on PROSPERO, CRD42022341952. Study quality was assessed using the NICE methodology. We looked at a total of six original articles. All studies gathered and presented quantitative data. Expert opinion: Our results suggest that new vaccinations could have more than 90% efficacy against SARS-CoV-2, regardless of the technology used. Furthermore, adverse reactions go from mild to moderate, and good immunogenicity can be observed for all vaccine types.
|
| Fecha Publicación |
2023
|
| Tipo de Recurso |
artículo de revisión
|
| doi |
10.1080/14760584.2023.2156861
|
| Formato Recurso |
PDF
|
| Palabras Claves |
Coronavirus
COVID vaccines
number of doses
vaccination
vaccine efficacy
vaccine platforms
|
| Ubicación del archivo | |
| Categoría OCDE |
Inmunología
|
| Materias |
Coronavirus
Vacunas para COVID-19
número de dosis
vacunación
eficacia de la vacuna
plataformas de vacunas
|
| Página de inicio (Recomendado-único) |
35.0
|
| Página final (Recomendado-único) |
53
|
| Identificador del recurso (Mandatado-único) |
artículo de revisión
|
| Versión del recurso (Recomendado-único) |
versión publicada
|
| License |
CC BY 4.0
|
| Condición de la licencia (Recomendado-repetible) |
CC BY 4.0
|
| Derechos de acceso |
acceso abierto
|
| Access Rights |
acceso abierto
|
| Id de Web of Science |
WOS:000899564300001
|
| ISSN |
1476-0584
|
| Tipo de ruta |
Verde# dorado
|
| Categoría WOS |
Inmunología
|
cienciaabierta.ufro.cl
ciencia.abierta@ufrontera.cl